Evaluating differentiation capacities and chromatin states in human iPSCs reveals significant variability, indicating Polycomb's role in fate determination.
iPSCs show substantial heterogeneity between individuals in their capacity to differentiate into various cell types, which is a major hurdle for regenerative cell therapies. To explore the causes of this variability, we assembled a panel of ten human iPSC lines, for which we evaluated the differentiation potential for two different fates, and profiled the transcriptome and epigenome. Using a custom-made computational method involving a Support Vector Machine, we dissected the different regulatory modes through which chromatin states affect transcription. We found that regulation of the Polycomb-mediated histone modification H3K27me3 at specific gene loci exhibited the most consistent differences among iPSC lines, frequently displaying a digital pattern (i.e., binary ON/OFF). We developed a mathematical model based on the read-write feedback of the Polycomb complex, which explained this behaviour. Overall, our findings demonstrate that the heterogeneity in digital Polycomb regulation mirrors the transcriptomic variability across the iPSC lines studied here. Notably, Polycomb heterogeneity was also correlated with the differentiation potentials of the iPSC lines, suggesting that chromatin variability could be one important factor influencing iPSC differentiation potential.
No takes yet. Share an insight, caveat, or question.
Miangolarra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: